Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Moses

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
JACC. Cardiovascular Interventions|February 4, 2019
In-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty: Insights From the OPEN-CTO RegistryAdam C Salisbury, Dimitri Karmpaliotis, J Aaron Grantham, et al.
JACC. Cardiovascular Interventions|March 5, 2021
Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement: REFLECT IITamim M Nazif, Jeffrey Moses, Rahul Sharma, et al.
JACC. Cardiovascular Interventions|May 26, 2009
A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experienceSimon R Dixon, José P S Henriques, Laura Mauri, et al.
The American Journal of Cardiology|September 21, 2016
Neurologic Complications of Unprotected Transcatheter Aortic Valve Implantation (from the Neuro-TAVI Trial)Alexandra J Lansky, David Brown, Constantino Pena, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 1, 2013
Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ΙΙ studyMauricio G Cohen, Abhijit Ghatak, Neal S Kleiman, et al.
Circulation. Cardiovascular Interventions|July 22, 2010
Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trialAlexandra J Lansky, Kenji Goto, Ecaterina Cristea, et al.
Journal of the American Heart Association|May 16, 2022
Predicting Residual Angina After Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from the OPEN-CTO RegistryNeel M Butala, Hector Tamez, Eric A Secemsky, et al.
JAMA|February 20, 2002
Fatal inhalational anthrax with unknown source of exposure in a 61-year-old woman in New York CityBushra Mina, J P Dym, Frank Kuepper, et al.
Critical Pathways in Cardiology|October 2, 2023
Updating a Healthcare System-wide Clinical Pathway for Managing Chest Pain and Acute Coronary SyndromesRobert S Zilinyi, Baruch S Fertel, Betty C Chang, et al.
Journal of the American College of Cardiology|March 19, 2004
First human experience with the 17-beta-estradiol-eluting stent: the Estrogen And Stents To Eliminate Restenosis (EASTER) trialAlexandre Abizaid, Mariano Albertal, Marco A Costa, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
JACC. Cardiovascular Interventions|February 4, 2019
In-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty: Insights From the OPEN-CTO RegistryAdam C Salisbury, Dimitri Karmpaliotis, J Aaron Grantham, et al.
JACC. Cardiovascular Interventions|March 5, 2021
Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement: REFLECT IITamim M Nazif, Jeffrey Moses, Rahul Sharma, et al.
JACC. Cardiovascular Interventions|May 26, 2009
A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experienceSimon R Dixon, José P S Henriques, Laura Mauri, et al.
The American Journal of Cardiology|September 21, 2016
Neurologic Complications of Unprotected Transcatheter Aortic Valve Implantation (from the Neuro-TAVI Trial)Alexandra J Lansky, David Brown, Constantino Pena, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 1, 2013
Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ΙΙ studyMauricio G Cohen, Abhijit Ghatak, Neal S Kleiman, et al.
Circulation. Cardiovascular Interventions|July 22, 2010
Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trialAlexandra J Lansky, Kenji Goto, Ecaterina Cristea, et al.
Journal of the American Heart Association|May 16, 2022
Predicting Residual Angina After Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from the OPEN-CTO RegistryNeel M Butala, Hector Tamez, Eric A Secemsky, et al.
JAMA|February 20, 2002
Fatal inhalational anthrax with unknown source of exposure in a 61-year-old woman in New York CityBushra Mina, J P Dym, Frank Kuepper, et al.
Critical Pathways in Cardiology|October 2, 2023
Updating a Healthcare System-wide Clinical Pathway for Managing Chest Pain and Acute Coronary SyndromesRobert S Zilinyi, Baruch S Fertel, Betty C Chang, et al.
Journal of the American College of Cardiology|March 19, 2004
First human experience with the 17-beta-estradiol-eluting stent: the Estrogen And Stents To Eliminate Restenosis (EASTER) trialAlexandre Abizaid, Mariano Albertal, Marco A Costa, et al.
Pageof 11